<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Exercise-related <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT) and high burden of <z:hpo ids='HP_0006682'>premature ventricular contractions</z:hpo> (<z:mp ids='MP_0010018'>PVCs</z:mp>) are common in arrhythmogenic right ventricular <z:mpath ids='MPATH_589'>dysplasia</z:mpath>/<z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesized that VT in arrhythmogenic right ventricular <z:mpath ids='MPATH_589'>dysplasia</z:mpath>/<z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> shows a high degree of association with the <z:mp ids='MP_0010018'>PVC</z:mp> at baseline </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: The study population included 16 consecutive arrhythmogenic right ventricular <z:mpath ids='MPATH_589'>dysplasia</z:mpath>/<z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> patients with recurrent VT who underwent catheter ablation </plain></SENT>
<SENT sid="3" pm="."><plain>Median age of the patients was 27 years (range, 18-66) and 50% were men </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had frequent ectopy at baseline with a median <z:mp ids='MP_0010018'>PVC</z:mp> count of 7275 (range, 1353-19 084) </plain></SENT>
<SENT sid="5" pm="."><plain>During EP study, a total of 27 VTs were induced, of which 16 (59%) occurred during high-dose <z:chebi fb="0" ids="6046">isoproterenol</z:chebi> infusion </plain></SENT>
<SENT sid="6" pm="."><plain>VT <z:mp ids='MP_0000002'>morphology</z:mp> was identical to the baseline <z:mp ids='MP_0010018'>PVCs</z:mp> in <z:hpo ids='HP_0000001'>all</z:hpo> the VTs induced during high-dose <z:chebi fb="0" ids="6046">isoproterenol</z:chebi> infusion </plain></SENT>
<SENT sid="7" pm="."><plain>Focal ablation at the site of earliest activation and 12/12 pace map of the <z:mp ids='MP_0010018'>PVC</z:mp> eliminated the VT in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="8" pm="."><plain>Target site for focal ablation localized to scar border </plain></SENT>
<SENT sid="9" pm="."><plain>Cumulative freedom from VT after ablation was 85.2% and 74.5% at 1 and 2 years, respectively, which was associated with a reduction in <z:mp ids='MP_0010018'>PVC</z:mp> count </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: We report a high degree of association between <z:mp ids='MP_0010018'>PVCs</z:mp> at baseline and the VTs induced during <z:chebi fb="2" ids="33567">catecholamine</z:chebi> infusion </plain></SENT>
<SENT sid="11" pm="."><plain>These VTs originated from the border region of scar most commonly in the right ventricular outflow tract and right ventricle basal regions </plain></SENT>
<SENT sid="12" pm="."><plain>These findings highlight the importance of <z:chebi fb="2" ids="33567">catecholamine</z:chebi> challenge and <z:mp ids='MP_0010018'>PVC</z:mp> mapping, which can in turn facilitate ablation of the VT in arrhythmogenic right ventricular <z:mpath ids='MPATH_589'>dysplasia</z:mpath>/<z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
</text></document>